18.12.2013 • News • Mergers & Acquisitions (M&A) • Pharmaceuticals • portfolio

Sartorius closes acquisition of TAP Biosystems Group

Sartorius continues to expand its bioprocess business
Sartorius continues to expand its bioprocess business

Sartorius, a leading international laboratory and pharmaceutical equipment provider, successfully completed its acquisition of UK company TAP Biosystems Group plc last Monday.  

The cash offer made through Sartorius' wholly owned subsidiary Sartorius Stedim Biotech valued TAP Biosystems Group plc at approximately €33 million and had been approved by TAP Biosystems' shareholders on November 21, 2013.  

The takeover of TAP Biosystems Group plc will enable Sartorius to further extend its bioprocess portfolio in the area of fermentation, especially in the early phases of product and process development. Founded in 1987, the company is headquartered in Royston, UK, generated sales revenue of approximately €26 million in 2012/2013 and employs around 160 people worldwide.   

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Top-Feature